Bridging Gaps in Long COVID Therapy: A Mini Review

View Full Paper

Ask AI

Bookmark

Authors

Discussion

Mini review highlights therapeutic strategies for long COVID, indicating gaps in diagnosis and treatment efficacy.

Main finding reveals 42% prevalence of long COVID, demonstrating its widespread impact on health.
Key evidence points to substantial variations in symptom duration, ranging from 3 months to 2 years.
Approach involved a critical analysis of therapeutic strategies, emphasizing both pharmacological and non-pharmacological options.
Significance highlights the urgent need for personalized approaches and more rigorous trials to improve patient quality of life.

Nori et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

View Full Paper

Ask AI

Bookmark

Authors

Mini review highlights therapeutic strategies for long COVID, indicating gaps in diagnosis and treatment efficacy.

Main finding reveals 42% prevalence of long COVID, demonstrating its widespread impact on health.
Key evidence points to substantial variations in symptom duration, ranging from 3 months to 2 years.
Approach involved a critical analysis of therapeutic strategies, emphasizing both pharmacological and non-pharmacological options.
Significance highlights the urgent need for personalized approaches and more rigorous trials to improve patient quality of life.

Nori et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark